Identification of phospholipase A2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action

Details for Australian Patent Application No. 2006204988 (hide)

Owner Novartis AG

Inventors Scherer, Andreas; Papoian, Ruben

Agent Davies Collison Cave

Pub. Number AU-A-2006204988

PCT Pub. Number WO2006/076414

Priority 60/643,990 14.01.05 US

Filing date 12 January 2006

Wipo publication date 20 July 2006

International Classifications

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/076414 Priority application(s): WO2006/076414

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204993-DNA markers for cattle growth

2006204977-Formulations for coated microprojections having controlled solubility